FUSAROLI, Michele; SALVO, Francesco; BEGAUD, Bernard; ALSHAMMARI, Thamir M; BATE, Andrew; BATTINI, Vera; BRUECKNER, Andreas; CANDORE, Gianmario; CARNOVALE, Carla; CRISAFULLI, Salvatore; CUTRONEO, Paola Maria; DOLLADILLE, Charles; DRICI, Milou-Daniel; FAILLIE, Jean-Luc; GOLDMAN, Adam; HAUBEN, Manfred; HERDEIRO, Maria Teresa; MAHAUX, Olivia; MANLIK, Katrin; MONTASTRUC, Francois; NOGUCHI, Yoshihiro; NOREN, G Niklas; NOSEDA, Roberta; ONAKPOYA, Igho J; PARIENTE, Antoine; POLUZZI, Elisabetta; SALEM, Myriam; SARTORI, Daniele; TRINH, Nhung T H; TUCCORI, Marco; VAN HUNSEL, Florence; VAN PUIJENBROEK, Eugene; RASCHI, Emanuel; KHOURI, Charles

doi:10.1007/s40264-024-01423-7

SALVO, Francesco
Bordeaux population health [BPH]

BEGAUD, Bernard
Bordeaux population health [BPH]

Langue

Article de revue

Ce document a été publié dans

Drug Safety. 2024-06-01, vol. 47, n° 6, p. 585-599

Résumé en anglais

In pharmacovigilance, disproportionality analyses based on individual case safety reports are widely used to detect safety signals. Unfortunately, publishing disproportionality analyses lacks specific guidelines, often leading to incomplete and ambiguous reporting, and carries the risk of incorrect conclusions when data are not placed in the correct context. The REporting of A Disproportionality analysis for drUg Safety signal detection using individual case safety reports in PharmacoVigilance (READUS-PV) statement was developed to address this issue by promoting transparent and comprehensive reporting of disproportionality studies. While the statement paper explains in greater detail the procedure followed to develop these guidelines, with this explanation paper we present the 14 items retained for READUS-PV guidelines, together with an in-depth explanation of their rationale and bullet points to illustrate their practical implementation. Our primary objective is to foster the adoption of the READUS-PV guidelines among authors, editors, peer reviewers, and readers of disproportionality analyses. Enhancing transparency, completeness, and accuracy of reporting, as well as proper interpretation of their results, READUS-PV guidelines will ultimately facilitate evidence-based decision making in pharmacovigilance.< Réduire

URI

https://oskar-bordeaux.fr/handle/20.500.12278/201248

DOI

http://dx.doi.org/10.1007/s40264-024-01423-7

Unités de recherche

Bordeaux Population Health Research Center (BPH) - UMR 1219

Voir/Ouvrir

Métadonnées

Partager cette publication !

Licence d’utilisation du document

The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration

Langue

Ce document a été publié dans

Résumé en anglais

URI

DOI

Unités de recherche